MELATONIN-PRIMED MESENCHYMAL STROMAL CELLS INTERFERE WITH TUMOR MICROENVIRONMENT DYNAMICS AND REDUCE GLIOBLASTOMA MALIGNANCY.

• Laura Olmedo Moreno,
• Paula Juárez Blázquez,
• Norma Adán Castro,
• Concepción Panadero Morón,
• Germaine Escames Rosa,
• Alejandro Martín Montalvo,
• José Manuel García Verdugo,
• Vivian Capilla-González

Affiliations

Laura Olmedo Moreno

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain

Paula Juárez Blázquez

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain

Norma Adán Castro

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain

Concepción Panadero Morón

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain

Germaine Escames Rosa

University of Granada, Department Of Physiology, Granada, Spain

Alejandro Martín Montalvo

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain

José Manuel García Verdugo

University of Valencia CIBERNED, Department Of Cell Biology, Valencia, Spain

Vivian Capilla-González

CABIMER, Department Of Integrative Pathophysiology And Therapies, Sevilla, Spain